Apogee, Spyre founder launch­es its third biotech and heads straight to Nas­daq

Af­ter cre­at­ing an­ti­body mak­ers Apogee and Spyre, Paragon Ther­a­peu­tics is back with an­oth­er in­flam­ma­to­ry and im­mune dis­ease biotech, and the start­up is im­me­di­ate­ly go­ing to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER